Cellix are pleased to announce the signing of an OEM manufacture and supply agreement with Cell Biolabs on a range of microfluidic biochips and accessories for cell-based assays. Cell-Biolabs, based in San Diego, CA, will supply the biochips from their current Cell-Based Assay product range thereby diversifying their product portfolio and entering into the microfluidics field.
Cellix is now supplying a range of biochips and accessories via an OEM supply agreement to Cell Biolabs. The microfluidic biochips will be streamlined in Cell Biolabs’ Cell-Based Assay portfolio and may be used for a wide range of applications including investigation of platelet biology, thrombi formation, the leukocyte adhesion cascade; biofilm formation and colonisation; and oncology studies. These biochips are compatible with standard syringe pumps from Harvard Apparatus, World Precision Instruments, KD Scientific and many more.
Vivienne Williams, CEO, Cellix commented on the deal: “This is an exciting development for Cellix. Cell Biolabs has great expertise in developing products for the cell-based assay field. They know and understand this market and having clearly recognised the benefits of microfluidics technology; such as reduced reagent and sample volumes, they can now incorporate this technology into their assay portfolio for the benefit of their customers.”
Ken Rosser, Director of Business Development at Cell Biolabs, San Diego, CA, USA; says “The Cellix biochips are a perfect fit for our Cell-Based Assay product portfolio. This technology will help us continue to achieve our goal of advancing cell biology research with innovative tools that facilitate discovery of the mechanisms underlying cell function and disease”.
Scientists map all yeast proteins across cell cycle for the first time